January 19, 2022

The World Live Breaking News Coverage & Updates IN ENGLISH

The World Live Breaking News Coverage & Updates IN ENGLISH

DGCI to review applications for full market approval of Covaxin, Covishield today

1 min read
DGCI to review applications for full market approval of Covaxin, Covishield today
Share This :
DGCI to review applications for full market approval of Covaxin, Covishield today
DGCI to review applications for full market approval of Covaxin, Covishield today

NEW DELHI: The Drugs Controller General of India (DCGI) headed Subject Expert Committee will review applications of Bharat Biotech and SII for full market approval to Covaxin and Covishield on Friday.
The move comes after the Hyderabad-based Bharat Biotech on Thursday announced that its indigenously developed Covid-19 vaccine Coavaxin is now a universal vaccine for adults and children.
In an application sent to the Drugs Controller General of India (DCGI) this week, V Krishna Mohan, Whole-Time Director at the Hyderabad-based company submitted complete information regarding chemistry, manufacturing and controls, along with pre-clinical and clinical data while seeking regular market authorisation for Covaxin.
Earlier, the manufacturer had claimed that its Covid vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.

The Serum Institute of India had already filed a similar plea for Covishield and both the applications will be reviewed by the subject expert committee (SEC) of the Drugs Controller General of India (DCGI).

Share This :
Copyright © All rights reserved. | Newsphere by AF themes.